Long-term effect of anifrolumab on patient-reported outcomes in systemic lupus erythematosus (TULIP-LTE): a randomised, placebo-controlled, phase 3 long-term extension trial
Vibeke Strand, Kenneth Kalunian, Kai Wai Lee, Caroline Seo, Gabriel Abreu, Raj Tummala, Hussein Al‐Mossawi, Elizabeth A. Duncan, Catharina Lindholm
Topics & Concepts
PlaceboMedicineTerm (time)Physical therapyRandomized controlled trialInternal medicinePediatricsAlternative medicinePathologyQuantum mechanicsPhysicsSystemic Lupus Erythematosus ResearchSpondyloarthritis Studies and TreatmentsRheumatoid Arthritis Research and Therapies